[CSF3R, ASXL1,SETBP1, JAK2 V617F and CALR mutations in chronic neutrophilic leukemia]

Zhonghua Xue Ye Xue Za Zhi. 2014 Dec;35(12):1069-73. doi: 10.3760/cma.j.issn.0253-2727.2014.12.005.
[Article in Chinese]

Abstract

Objective: To observe the CSF3R, ASXL1, SETBP1, JAK2 V617F and CALR mutations in patients with chronic neutrophilic leukemia (CNL).

Methods: Twelve suspected "CNL" patients were retrospectively reviewed according the WHO criteria (2008). CSF3R,ASXL1,SETBP1 and CALR mutations were sequenced, and JAK2 V617F was tested by allele specific (AS)-PCR.

Results: 6 of 12 cases were diagnosed as CML, and all of the 6 carried. 4 of 6 patients also had ASXL1 and SETBP1 mutations and one had a CALR mutation (c.1154-1155insTTGTC). Two patients with monoclonal gammopathy with uncertain significance (MGUS) combined with CNL-like symptoms had no CSF3R, ASXL1, SETBP1, JAK2 V617F or CALR mutation. The same results were also seen in other 4 cases with secondary neutrophilic leukocytosis.

Conclusion: CSF3R, ASXL1 and SETBP1 mutations differential diagnosis of CNL, and should be included in the diagnostic protocol so as to improve diagnostic accuracy for CNL.

MeSH terms

  • Carrier Proteins
  • Humans
  • Janus Kinase 2
  • Leukemia, Neutrophilic, Chronic*
  • Mutation*
  • Nuclear Proteins
  • Polymerase Chain Reaction
  • Receptors, Colony-Stimulating Factor
  • Repressor Proteins
  • Retrospective Studies

Substances

  • ASXL1 protein, human
  • CSF3R protein, human
  • Carrier Proteins
  • Nuclear Proteins
  • Receptors, Colony-Stimulating Factor
  • Repressor Proteins
  • SETBP1 protein, human
  • JAK2 protein, human
  • Janus Kinase 2